502 related articles for article (PubMed ID: 21145399)
21. Calnexin inhibits thermal aggregation and neurotoxicity of prion protein.
Wang W; Chen R; Luo K; Wu D; Huang L; Huang T; Xiao G
J Cell Biochem; 2010 Oct; 111(2):343-9. PubMed ID: 20506117
[TBL] [Abstract][Full Text] [Related]
22. Modulation of Glycosaminoglycans Affects PrPSc Metabolism but Does Not Block PrPSc Uptake.
Wolf H; Graßmann A; Bester R; Hossinger A; Möhl C; Paulsen L; Groschup MH; Schätzl H; Vorberg I
J Virol; 2015 Oct; 89(19):9853-64. PubMed ID: 26202247
[TBL] [Abstract][Full Text] [Related]
23. Heparin binding by murine recombinant prion protein leads to transient aggregation and formation of RNA-resistant species.
Vieira TC; Reynaldo DP; Gomes MP; Almeida MS; Cordeiro Y; Silva JL
J Am Chem Soc; 2011 Jan; 133(2):334-44. PubMed ID: 21142149
[TBL] [Abstract][Full Text] [Related]
24. Glycosaminoglycan sulfation determines the biochemical properties of prion protein aggregates.
Ellett LJ; Coleman BM; Shambrook MC; Johanssen VA; Collins SJ; Masters CL; Hill AF; Lawson VA
Glycobiology; 2015 Jul; 25(7):745-55. PubMed ID: 25701659
[TBL] [Abstract][Full Text] [Related]
25. In vitro conversion of full-length mammalian prion protein produces amyloid form with physical properties of PrP(Sc).
Bocharova OV; Breydo L; Parfenov AS; Salnikov VV; Baskakov IV
J Mol Biol; 2005 Feb; 346(2):645-59. PubMed ID: 15670611
[TBL] [Abstract][Full Text] [Related]
26. Prion encephalopathies of animals and humans.
Prusiner SB
Dev Biol Stand; 1993; 80():31-44. PubMed ID: 8270114
[TBL] [Abstract][Full Text] [Related]
27. Towards cellular receptors for prions.
Lee KS; Linden R; Prado MA; Brentani RR; Martins VR
Rev Med Virol; 2003; 13(6):399-408. PubMed ID: 14625887
[TBL] [Abstract][Full Text] [Related]
28. Amyloid formation by recombinant full-length prion proteins in phospholipid bicelle solutions.
Lührs T; Zahn R; Wüthrich K
J Mol Biol; 2006 Mar; 357(3):833-41. PubMed ID: 16466741
[TBL] [Abstract][Full Text] [Related]
29. Prion protein interactions with nucleic acid: possible models for prion disease and prion function.
Grossman A; Zeiler B; Sapirstein V
Neurochem Res; 2003 Jun; 28(6):955-63. PubMed ID: 12718450
[TBL] [Abstract][Full Text] [Related]
30. The structure of prion: is it enough for interpreting the diverse phenotypes of prion diseases?
Tian C; Dong X
Acta Biochim Biophys Sin (Shanghai); 2013 Jun; 45(6):429-34. PubMed ID: 23459557
[TBL] [Abstract][Full Text] [Related]
31. Prion diseases: from molecular biology to intervention strategies.
Nunziante M; Gilch S; Schätzl HM
Chembiochem; 2003 Dec; 4(12):1268-84. PubMed ID: 14661267
[TBL] [Abstract][Full Text] [Related]
32. The emerging principles of mammalian prion propagation and transmissibility barriers: Insight from studies in vitro.
Surewicz WK; Jones EM; Apetri AC
Acc Chem Res; 2006 Sep; 39(9):654-62. PubMed ID: 16981682
[TBL] [Abstract][Full Text] [Related]
33. Cellular prion protein mediates toxic signaling of amyloid beta.
Resenberger UK; Winklhofer KF; Tatzelt J
Neurodegener Dis; 2012; 10(1-4):298-300. PubMed ID: 22156337
[TBL] [Abstract][Full Text] [Related]
34. Insights into prion strains and neurotoxicity.
Aguzzi A; Heikenwalder M; Polymenidou M
Nat Rev Mol Cell Biol; 2007 Jul; 8(7):552-61. PubMed ID: 17585315
[TBL] [Abstract][Full Text] [Related]
35. Proteomic analysis of prion diseases: creating clarity or causing confusion?
Rubenstein R
Electrophoresis; 2012 Dec; 33(24):3631-43. PubMed ID: 23161058
[TBL] [Abstract][Full Text] [Related]
36. PrP interactions with nucleic acids and glycosaminoglycans in function and disease.
Silva JL; Gomes MP; Vieira TC; Cordeiro Y
Front Biosci (Landmark Ed); 2010 Jan; 15(1):132-50. PubMed ID: 20036811
[TBL] [Abstract][Full Text] [Related]
37. Prion protein: structural features and related toxicity.
Hu PP; Huang CZ
Acta Biochim Biophys Sin (Shanghai); 2013 Jun; 45(6):435-41. PubMed ID: 23615535
[TBL] [Abstract][Full Text] [Related]
38. Interaction between misfolded PrP and the ubiquitin-proteasome system in prion-mediated neurodegeneration.
Lin Z; Zhao D; Yang L
Acta Biochim Biophys Sin (Shanghai); 2013 Jun; 45(6):477-84. PubMed ID: 23449072
[TBL] [Abstract][Full Text] [Related]
39. The prion protein unstructured N-terminal region is a broad-spectrum molecular sensor with diverse and contrasting potential functions.
Béland M; Roucou X
J Neurochem; 2012 Mar; 120(6):853-68. PubMed ID: 22145935
[TBL] [Abstract][Full Text] [Related]
40. Unraveling Prion Protein Interactions with Aptamers and Other PrP-Binding Nucleic Acids.
Macedo B; Cordeiro Y
Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28513534
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
